On December 7, 2023, the Biden administration announced a blueprint for a framework that may be a tough pill to swallow for the pharmaceutical industry. This framework suggests that drug prices should be a crucial factor in...more
12/12/2023
/ Bayh-Dole Act ,
Biden Administration ,
Drug Pricing ,
Food & Drug Regulations ,
Healthcare ,
Healthcare Reform ,
Inventions ,
Life Sciences ,
Patents ,
Pharmaceutical Industry ,
Pharmaceutical Patents ,
Prescription Drugs ,
R&D ,
Regulatory Agenda ,
Research and Development
President Biden signed a comprehensive Executive Order addressing AI regulation across a wide range of industries and issues. Intellectual property is a key focus. The Order calls on the U.S. Copyright Office and U.S. Patent...more
11/2/2023
/ Artificial Intelligence ,
Biden Administration ,
Copyright ,
Copyright Infringement ,
Copyright Office ,
Executive Orders ,
Intellectual Property Litigation ,
Intellectual Property Protection ,
Machine Learning ,
Patent Infringement ,
Patents ,
Risk Mitigation ,
USPTO